Form 8-K - Current report:
SEC Accession No. 0001193125-25-300647
Filing Date
2025-11-26
Accepted
2025-11-26 16:30:26
Documents
10
Period of Report
2025-11-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K vera-20251125.htm   iXBRL 8-K 44686
  Complete submission text file 0001193125-25-300647.txt   150582

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vera-20251125.xsd EX-101.SCH 25003
12 EXTRACTED XBRL INSTANCE DOCUMENT vera-20251125_htm.xml XML 4779
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 251530793
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)